These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24603476)

  • 1. Rapamycin slows IgA nephropathy progression in the rat.
    Tian J; Wang Y; Zhou X; Li Y; Wang C; Li J; Li R
    Am J Nephrol; 2014; 39(3):218-29. PubMed ID: 24603476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option.
    Tian J; Wang Y; Guo H; Li R
    Exp Mol Pathol; 2015 Dec; 99(3):435-40. PubMed ID: 26297427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms.
    Tian J; Wang Y; Liu X; Zhou X; Li R
    Exp Biol Med (Maywood); 2015 Jul; 240(7):936-45. PubMed ID: 25349217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin Enhances Repressed Autophagy and Attenuates Aggressive Progression in a Rat Model of IgA Nephropathy.
    Liu D; Liu Y; Chen G; He L; Tang C; Wang C; Yang D; Li H; Dong Z; Liu H
    Am J Nephrol; 2017; 45(4):293-300. PubMed ID: 28237991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
    Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy.
    Chen X; Peng S; Zeng H; Fu A; Zhu Q
    Indian J Pharmacol; 2015; 47(1):27-33. PubMed ID: 25821307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect and mechanism of rapamycin in the rat model of IgA nephropathy.
    Guo N; Liu S; Bow LM; Cui X; Zhang L; Xu S; Lu S; Tian J
    Ren Fail; 2019 Nov; 41(1):334-339. PubMed ID: 31057050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The study of Chinese medicinal herbal formula Shen San Fang in the treatment of experimental IgA nephropathy.
    Zhong Q; Leung JC; Chan LY; Tsang AW; Chen X; Lai KN
    Am J Chin Med; 2005; 33(4):613-26. PubMed ID: 16173535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
    Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J
    Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.
    Bonegio RG; Fuhro R; Wang Z; Valeri CR; Andry C; Salant DJ; Lieberthal W
    J Am Soc Nephrol; 2005 Jul; 16(7):2063-72. PubMed ID: 15917339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of the activated mammalian target of rapamycin pathway might be associated with renal function reserve by a low-protein diet in the rat remnant kidney model.
    Ohkawa S; Yanagida M; Uchikawa T; Yoshida T; Ikegaya N; Kumagai H
    Nutr Res; 2013 Sep; 33(9):761-71. PubMed ID: 24034576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rapamycin in the Eker rat model of tuberous sclerosis complex.
    Kenerson H; Dundon TA; Yeung RS
    Pediatr Res; 2005 Jan; 57(1):67-75. PubMed ID: 15557109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of astragalus on renal tubulointerestitial lesions and expression of NF-kappaB and MCP-1 in renal tissues in rat experimental IgA nephropathy].
    Zhang GZ; Wu XC; Peng XJ; Yi ZW; Mo SH; Tan H
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):173-8. PubMed ID: 18433541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced IgA nephropathy with impaired renal function benefits from losartan treatment in rats.
    Wang H; Fu W; Jin Z; Wang Y; Yao W; Yin P; Peng W
    Ren Fail; 2013 Jul; 35(6):812-8. PubMed ID: 23751143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hirudin ameliorates immunoglobulin A nephropathy by inhibition of fibrosis and inflammatory response.
    Deng F; Zhang J; Li Y; Wang W; Hong D; Li G; Feng J
    Ren Fail; 2019 Nov; 41(1):104-112. PubMed ID: 30880546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
    Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
    J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma gelsolin levels are decreased and correlate with fibrosis in IgA nephropathy.
    Han C; Zhang L; Zhu X; Tang J; Jin X
    Exp Biol Med (Maywood); 2013 Nov; 238(11):1318-27. PubMed ID: 24047794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
    Leung JC; Chan LY; Tsang AW; Liu EW; Lam MF; Tang SC; Lai KN
    Nephrol Dial Transplant; 2004 Aug; 19(8):1976-85. PubMed ID: 15187193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.